NCT02628223

Brief Summary

Selective laser trabeculoplasty (SLT) is a well-recognized way to lower eye pressure in treatment of glaucoma. This treatment is performed for 180 degrees or 360 degrees, and studies at academic centers have shown mixed results when comparing the success rates of 180 degrees or 360 degrees. Both protocols are now typically done by comprehensive ophthalmologists. However, there is no data that compares success rates of 180 degrees and 360 degrees in the community setting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

November 23, 2015

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 11, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
2.9 years until next milestone

Results Posted

Study results publicly available

November 5, 2020

Completed
Last Updated

November 5, 2020

Status Verified

November 1, 2020

Enrollment Period

3.3 years

First QC Date

November 23, 2015

Results QC Date

October 12, 2020

Last Update Submit

November 3, 2020

Conditions

Keywords

glaucomaElevated IOPSelective Laser TrabeculoplastySLTopen angle glaucomaocular hypertensionGlaucoma, Open Angle, Pseudo-exfoliativepigment dispersion syndromePseudoexfoliationIOP ≥ 21 mmHg

Outcome Measures

Primary Outcomes (1)

  • Intraocular Pressure (IOP) Measured by Tonometry in Millimeters of Mercury at Three Months of Follow-up

    Intraocular pressure (IOP) measured by tonometry in millimeters of mercury at three months of follow-up

    3 months

Secondary Outcomes (3)

  • Intraocular Pressure (IOP) Measured by Tonometry in Millimeters of Mercury at 1 Year of Follow-up

    1 year

  • Intraocular Pressure (IOP) Measured by Tonometry in Millimeters of Mercury at Time at Which Additional Glaucoma Therapy is Required

    within 1 year of study intervention

  • Intraocular Pressure (IOP) Measured by Tonometry in Millimeters of Mercury at Last Follow-up

    within 1 year of study intervention

Other Outcomes (2)

  • Number of Participants With Intraocular Pressure (IOP) Spike Assessed by Tonometry

    within 1 year of study intervention

  • Number of Participants With Trabeculitis Assessed by Ophthalmic Exam and Gonioscopy

    within 1 year of study intervention

Study Arms (2)

180 degrees

ACTIVE COMPARATOR

180 degrees of Selective Laser Trabeculoplasty using Neodymium:Yttrium Aluminum Garnet (YAG) laser

Procedure: Selective Laser TrabeculoplastyDevice: Neodymium:Yttrium Aluminum Garnet (YAG) laser

360 degrees

ACTIVE COMPARATOR

360 degrees of Selective Laser Trabeculoplasty using Neodymium:Yttrium Aluminum Garnet (YAG) laser

Procedure: Selective Laser TrabeculoplastyDevice: Neodymium:Yttrium Aluminum Garnet (YAG) laser

Interventions

The procedure uses light energy provided by a neodymium (Nd):Yttrium Aluminum Garnet (YAG) laser that is directed into the iridocorneal angle via a goniolens viewed through a standard slit lamp.

Also known as: SLT
180 degrees360 degrees

The procedure uses a 400 μm spot size of light energy provided by a low-energy, Q-switched, frequency-doubled (532 nm) neodymium (Nd):Yttrium Aluminum Garnet (YAG) laser with a short pulse duration of 3 nanoseconds that is directed into the iridocorneal angle via a goniolens viewed through a standard slit lamp.

Also known as: Nd:YAG laser
180 degrees360 degrees

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients who have been diagnosed with open-angle glaucoma including ocular hypertension, pseudoexfoliation and pigment dispersion syndrome
  • greater than 18 years of age
  • initial intraocular pressure (IOP) of ≥ 21 mmHg

You may not qualify if:

  • prior medical or laser therapy to lower IOP
  • previous incisional glaucoma surgery before the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Brandywine Eye Center

Wilmington, Delaware, 19810, United States

Location

Levin Luminais Chronister Eye Associates

Thorndale, Pennsylvania, 19372, United States

Location

MeSH Terms

Conditions

Glaucoma, Open-AngleOcular HypertensionGlaucomaGlaucoma-Related Pigment Dispersion Syndrome

Interventions

Lasers

Condition Hierarchy (Ancestors)

Eye Diseases

Intervention Hierarchy (Ancestors)

Optical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Limitations and Caveats

There were some limitations to this study that include: No standardized definition of who needed laser; No standardized technique other than the amount of meshwork lasered; No standardized IOP checking device; No standardized post op drop regimen; No standardized follow up interval.

Results Point of Contact

Title
Dr. Jeffrey Henderer
Organization
Temple University Hospital

Study Officials

  • Jeffrey D. Henderer, MD

    Temple University

    PRINCIPAL INVESTIGATOR
  • Sophia Siu, MD

    Temple University

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2015

First Posted

December 11, 2015

Study Start

September 1, 2014

Primary Completion

December 1, 2017

Study Completion

December 1, 2017

Last Updated

November 5, 2020

Results First Posted

November 5, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations